Showing results (111-120 of 146) with videos related to
Sort By:
Pageof 15
Leukemia|July 12, 2024
Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibitionSana Chaudhry, Felipe Beckedorff, Shaista Shabbir Jasdanwala, et al.Nature|October 11, 2019
Spliceosomal disruption of the non-canonical BAF complex in cancerDaichi Inoue, Guo-Liang Chew, Bo Liu, et al.Nature Medicine|May 3, 2016
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteinsStanley Chun-Wei Lee, Heidi Dvinge, Eunhee Kim, et al.Nature|July 5, 2019
Somatic mutations and cell identity linked by Genotyping of TranscriptomesAnna S Nam, Kyu-Tae Kim, Ronan Chaligne, et al.Blood|July 30, 2025
XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid MalignanciesTraci L Kruer, Ariel Quintana-Gonzalez, Hannah L Newman, et al.Blood|August 13, 2017
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterationsBenjamin H Durham, Bartlomiej Getta, Sascha Dietrich, et al.Blood|June 4, 2017
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMMLAkihide Yoshimi, Maria E Balasis, Alexis Vedder, et al.Cancer Research|June 18, 2025
XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome ChemoresistanceTulasigeri M Totiger, Wannasiri Chiraphapphaiboon, Yasmine Baca, et al.Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.The Journal of Clinical Investigation|June 20, 2018
Oncogenic TRK fusions are amenable to inhibition in hematologic malignanciesJustin Taylor, Dean Pavlick, Akihide Yoshimi, et al.Pageof 15